Drug Type Small molecule drug |
Synonyms DUOLANS |
Action antagonists, inhibitors |
Mechanism D2 receptor antagonists(Dopamine D2 receptor antagonists), Proton pump inhibitors |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date- |
Regulation- |
Molecular FormulaC22H24ClN5O2 |
InChIKeyFGXWKSZFVQUSTL-UHFFFAOYSA-N |
CAS Registry57808-66-9 |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Dyspepsia | Turkey | - | |
| Gastroesophageal Reflux | Turkey | - |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Gastroesophageal Reflux | Preclinical | Turkey | 28 Nov 2017 |





